Cambridge: AstraZeneca has received approval for Imfinzi (durvalumab) in the European Union (EU) for the treatment of adult ...

Bengaluru: AstraZeneca is reportedly in discussions with Summit Therapeutics to license an experimental lung cancer drug in a ...

British businesses worth more than half a trillion pounds in total could quit the stock market, analysts have warned.

Union Minister Piyush Goyal on Saturday demanded that Karnataka Chief Minister Siddaramaiah apologise to the country’s ...

Precision oncology has entered a new phase, as data sets mature and a new wave of tools emerges to help clinicians manage ...

With investor nervousness on the rise, Zaven Boyrazian explores the category of UK shares that could potentially outperform ...

Everyone on the full state pension will be forced to pay income tax as early as next year - even if they have no other income ...

Approval based on NIAGARA Phase III trial results which showed a 32% reduction in the risk of recurrence and a 25% reduction in the risk of death for the ...

Find the best undervalued stocks to buy in 2025. Learn which top global companies offer strong potential for smart investing and dividend growth.